Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-20-025969

Director sold 3,035 shares at $86.87 ($263,636)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2020-09-18 Sale −3,035 $86.87 $263,636 518,190 I
Open-market sales · 3,035 sh · avg $86.87 · $263,636
Loading xslF345X03/doc4.xml…